IL10 and neoplasm: Since our results demonstrated that IL-10 and IL-6 cytokines levels are crucial in defining the antitumoral action of mifamurtide, we first assayed cell viability of OS tumor cells treated with mifamurtide in the presence or absence of anti-IL-10 and anti-IL-6 blocking antibodies.